Table 1 Genotypes for all markers on all patients.

From: Human Genetic Susceptibility of Leprosy Recurrence

Gene

Marker

Risk Allele

Frequency on recurrent cases

Frequency on controls

Frequency on public databasea

Cases

Controls

3208

1126*

2188

9162

9638

9536

IL10

rs1800871

A

0.67

0.50

0.43

AG

AA

AG

AA

AG

GG

PARK2/PACRG

rs2803073

G

0.17

0.33

0.34

AA

AG

AA

AG

AG

AA

rs1040079

G

0.67

0.0

0.32

GG

AA

GG

AA

AA

AA

rs2276201

C

0.67

0.0

0.41

CC

TT

CC

TT

TT

TT

rs9356058

T

0.67

0.17

0.75

TT

CC

TT

CC

CT

CC

SOD2

rs4880

G

0.33

0.50

0.41

AG

AA

AG

AG

AA

GG

NEBL

rs625903

G

0.33

0.67

0.59

AA

AG

AG

AG

AG

GG

CCDC122/LACC1

rs2275252

C

0.17

0.33

0.61

AA

AC

AA

AC

AC

AA

rs4942254

T

0.17

0.33

0.57

CC

CT

CC

CT

CT

CC

NOD2

rs8057341

G

1.00

0.67

0.52

GG

GG

GG

GG

AG

AG

rs3135499

A

0.17

0.50

0.64

CC

AC

CC

AC

AC

AC

rs2111234

A

0.83

0.67

0.51

AA

AG

AA

AA

AG

AG

HLA-DRB1/DQA1

rs602875

A

0.83

0.67

0.73

AA

AG

AA

AG

AG

AA

rs1071630

T

0.67

0.50

0.45

TT

CC

TT

CT

CT

CT

LTA

rs2239704

A

0.50

0.50

0.35

AA

AC

CC

CC

AA

AC

rs909253

A

0.67

0.67

0.61

AA

AG

AG

GG

AA

AA

GATA3

rs10905284

C

0.67

0.67

0.56

AC

AC

CC

AC

CC

AC

IFNG

rs2069727

T

0.83

0.50

0.73

CT

TT

TT

TT

CC

CT

TLR1

rs4833095

C

0.83

0.33

0.57

CC

CC

CT

CT

CT

TT

  1. A: adenine, G: guanine, C: cytosine, T: thymine. *Patient suspected of reinfection
  2. a: Data from 1000 genomes, phase 3, all superpopulations combined, obtained on Ensembl Genome Browser.